Experiment description of studies that identified MYO15B in exosomes

1 Experiment ID 1203 MISEV standards ✔ EM EV Biophysical techniques ✔ SDCBP|FLOT1|CD9|CD81|CD63|EPCAM|GAPDH|LAMP1|TFRC|CD151|CD82|LAMP2|RAB35|TSG101|FLOT2|RAB5B|ICAM1|RAB5A EV Enriched markers ✘ EV Negative markers ✘ EV Particle analysis Identified molecule protein Identification method Mass spectrometry PubMed ID 34887515     Organism Homo sapiens Experiment description Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets Authors Zhang Q, Jeppesen DK, Higginbotham JN, Graves-Deal R, Trinh VQ, Ramirez MA, Sohn Y, Neininger AC, Taneja N, McKinley ET, Niitsu H, Cao Z, Evans R, Glass SE, Ray KC, Fissell WH, Hill S, Rose KL, Huh WJ, Washington MK, Ayers GD, Burnette DT, Sharma S, Rome LH, Franklin JL, Lee YA, Liu Q, Coffey RJ. Journal name Nat Cell Biol Publication year 2021 Sample Colorectal cancer cells Sample name DiFi Isolation/purification methods Differential centrifugation Filtration Centrifugal ultrafiltration Ultracentrifugation OptiPrep density gradient centrifugation Flotation density - Molecules identified in the study Protein miRNA Methods used in the study Western blotting Mass spectrometry RNA sequencing

Protein-protein interactions for MYO15B

Protein Interactor ExoCarta ID Identification method PubMed Species 1 GFAP 2670 Two-hybrid Homo sapiens 2 NADSYN1 55191 Two-hybrid Homo sapiens 3 TRIM29 23650 Two-hybrid Homo sapiens 4 ZBTB8   Two-hybrid Homo sapiens 5 RAD54B   Two-hybrid Homo sapiens 6 SSSCA1 10534 Two-hybrid Homo sapiens View the network

Pathways in which MYO15B is involved

No pathways found